Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide. Phase 1, Open-Label, Fixed-Sequence, 2-Period Study to Estimate the Effect of Multiple-Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of
Single-Dose Tolbutamide in Healthy Participants.
Category & Conditions: Immune System Diseases and Conditions
Medicine: ritlecitinib (PF-06651600)
ClinicalTrials.gov Identifier (NCT): NCT05097716
Protocol ID: B7981069
PrintDownloadOpen Plain Language Summary Result: Click here